pharmaphorum May 11, 2023
By Phil Taylor

It’s been 20 years since the Human Genome Project published its first blueprint of human gene sequences, starting a new era of medical research, but now scientists have gone one better.

Enter the pangenome, a map that tackles one of the key limitations of the first iteration – namely, its lack of diversity, as most of the sequencing was done on DNA from one American male with European and African ancestry. It also covered around 92% of genetic material, with the remainder uncharted.

The first draft of the pangenome fills in those missing sections of the map, but also covers distinct genomes from 47 individuals from a diverse range of ancestries from all continents in the world, with the exception...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article